STOCK TITAN

Shakeology by BODi Enters Retail Stores Nationwide, Marking a Major Expansion in the Company’s Nutrition-Led Strategy

(Very Positive)
Tags

Key Terms

prebiotics medical
Prebiotics are indigestible fibers or compounds that selectively feed and encourage the growth of beneficial bacteria in the gut, acting like fertilizer for the microbiome. They matter to investors because consumer demand, product formulations, clinical research and regulatory approval around prebiotic claims can directly affect sales, margins and long-term growth in food, supplement and biotech companies—similar to how a new ingredient can reshape a product market.
probiotics medical
Live microorganisms, often called "good" bacteria, that are added to foods or supplements and are intended to support health when taken in sufficient amounts; think of them as friendly tenants that help keep your gut environment balanced. For investors, probiotics matter because consumer demand, scientific evidence, and regulatory rules determine market size, product labeling, manufacturing standards and potential legal or reimbursement risks, all of which affect sales and company valuations.
adaptogens medical
Adaptogens are herbs or natural supplements marketed to help the body better cope with physical, mental or environmental stress, like a thermostat that helps keep a room’s temperature steady. For investors, they matter because consumer demand, product positioning and regulatory limits on health claims drive sales prospects and legal risk — strong market interest can boost revenue but vague scientific backing and evolving rules can create volatility.
digestive enzymes medical
Digestive enzymes are natural proteins the body (or a supplement) uses to break down food into smaller parts it can absorb, like kitchen scissors cutting pieces of a meal into bite-sized portions. For investors, they matter because enzyme products and therapies affect product effectiveness, clinical outcomes, regulatory approvals, labeling claims and consumer demand in pharmaceuticals, medical foods and supplements, which all influence sales, reimbursement and company valuations.
antioxidants medical
Antioxidants are substances—molecules found in foods, supplements, and medicines—that slow or stop chemical processes that can damage cells, similar to how a rust inhibitor or a small fire extinguisher prevents wear and tear. Investors care because antioxidant claims and evidence can drive consumer demand, affect product labeling and regulatory scrutiny, influence clinical trial outcomes, and therefore shape sales, reputations, and the valuation of companies in food, wellness and pharmaceutical markets.
whey isolate medical
Whey isolate is a highly concentrated protein powder made by filtering milk to remove most fats and sugars, leaving nearly pure protein in a lightweight, powder form used in protein shakes, bars and food products. Investors watch it because demand and pricing reflect consumer fitness trends, food-manufacturing needs and dairy-supply costs, so shifts in popularity, ingredient shortages, or changes in production costs can affect sales, margins and the outlook for companies that make or sell it.
randomized medical
Randomized means participants or units in a study are assigned to different groups by chance rather than by choice, like flipping a coin to decide who gets a new treatment and who gets a comparison. For investors, randomized designs matter because they reduce bias and make results more trustworthy, so outcomes from randomized studies carry more weight when assessing regulatory approval, commercial prospects, and the risk that trial results will change a company’s valuation.
double-blind, placebo-controlled medical
A clinical trial design in which participants are randomly assigned to receive either the experimental treatment or an inactive substitute (a placebo), and neither the participants nor the researchers know who is receiving which. This setup limits bias and makes it far easier to tell whether a drug or intervention truly works, similar to a blind taste test, so results carry more weight for regulatory decisions and for investors assessing a product’s commercial prospects.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

The original protein and superfood shake will debut in retail nationwide at Sprouts Farmers Market

BODi expands national retail reach through strategic partnership with KeHE Distributors

EL SEGUNDO, Calif.--(BUSINESS WIRE)-- BODi (NASDAQ: BODI), the proactive wellness company delivering nutrition, supplements, and proven fitness programs that help people take control of their health inside and out, today announced that its premium protein and superfood nutrition solution, Shakeology®, will launch at more than 80 Sprouts Farmers Market locations nationwide on May 18. BODi has also secured a strategic partnership with KeHE Distributors, a national distributor focused on natural, organic, fresh, and specialty products, expanding with KeHE’s potential reach across grocery, supermarket, and online channels to more than 30,000 retail locations.

Shakeology by BODi enters retail stores nationwide, marking major expansion in the company’s nutrition-led strategy.

Shakeology by BODi enters retail stores nationwide, marking major expansion in the company’s nutrition-led strategy.

Originally introduced in 2009, Shakeology pioneered the protein and superfood shake category, providing a simple way to get essential nutrients from fruits and vegetables in a single 160-calorie shake. Since launch, Shakeology has generated more than $4 billion in cumulative sales through direct-to-consumer channels and has delivered more than 1 billion servings.

For the first time, consumers will find Shakeology on shelves at Sprouts nationwide in a convenient seven-serving bag, priced at $34.99 and available in four flavors:

  • Chocolate Whey
  • Chocolate Vegan
  • Tropical Strawberry Vegan
  • Vanilla Vegan

“Shakeology started as my own personal need as a better way to get real nutrition into my diet without sacrificing taste,” said Carl Daikeler, co-founder and CEO of BODi. “Expanding into retail is a natural progression, and I’m proud and excited to see it at Sprouts, making it easier for more people to access a proven, everyday nutrition solution that’s already delivered real results for millions.”

Shakeology is formulated as an all-in-one superfood and protein nutrition shake, combining high-quality protein with fiber, prebiotics and probiotics, vitamins, minerals, and more than 30 superfoods, including adaptogens, digestive enzymes, antioxidants and greens. The vegan formula delivers 16 grams of protein from a plant-based blend of peas, quinoa, rice and flax, while the whey formula provides 17 grams of protein from whey isolate and also includes the same plant-based ingredients, all in a single serving of around 160 calories when mixed with water.

The product is designed to help support energy, gut health, digestion and regularity, while promoting lean muscle, bone health and a healthy immune system. Shakeology also helps protect against free radicals and oxidative stress, reduce cravings, and support weight loss as shown in a clinical study1 published in the Journal of Nutrition with participants who consumed Shakeology.

BODi Expands Distribution To Solidify Its Multi-Channel Growth Strategy

BODi’s strategic distribution partnership with KeHE aims to significantly increase accessibility for Shakeology, helping position the brand for rapid scale. The Shakeology launch into Sprouts, led to the partnership with KeHE, representing a critical inflection point in BODi’s retail expansion.

“We’ve seen that the strongest results come from combining effective nutrition with our proven digital fitness,” added Daikeler. “What’s changed is that nutrition has become the most efficient entry point for many people. Since the supplement market is more than 12 times the size of digital fitness, launching Shakeology into retail and partnering with KeHE gives us a new opportunity to reach millions.”

With KeHE’s expansive network and deep relationships across the natural food and wellness retail landscape, BODi is now positioned to quickly expand into new accounts and channels. As part of this strategy, BODi is also expanding its nutrition portfolio across some of its most recognizable brands, including P90X and INSANITY. In addition to the new line of P90X supplements that launched in March 2026, planned innovations include testing new energy beverages in select markets, a ready-to-drink Shakeology product, and protein bars expected to launch later this year.

Each Shakeology purchase includes free access to BODi’s digital fitness platform, reinforcing the company’s integrated approach to proactive wellness, ultimately combining daily nutrition with structured, results-driven fitness.

To locate the nearest Sprouts store, go to: www.sprouts.com/stores. Shakeology can also be purchased directly on BODi.com where it’s available in additional flavors including Café Latté and Cookies & Creamy.

¹Based on a 12-week randomized, double-blind, placebo-controlled clinical study published in the Journal of Nutrition.

About BODi and The Beachbody Company

BODi is a proactive wellness company delivering nutrition, supplements and proven fitness programs that help people take control of their health inside and out. With nearly three decades of experience, BODi, formerly Beachbody, has evolved from a leader in home fitness into a comprehensive health and fitness ecosystem designed to help people achieve their goals and lead healthier, more fulfilling lives. Anchored by science-backed nutrition solutions like Shakeology and supported by its portfolio of proven fitness and habit-building programs, including P90X and INSANITY, BODi is creating a more accessible and effective path to long-term health.

Since its inception, BODi has supported more than 30 million customers in achieving lasting results. The company continues to innovate across nutrition and digital fitness to deliver simple, proven solutions for modern lifestyles.

To subscribe and shop, visit BODi.com. For company and investor information, please visit TheBeachbodyCompany.com.

Media Relations:
BODi@aiir.agency

Investor Relations:
IR@BODi.com

Source: BODi